S&P ASX All Technology

3,077.90

0.00%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

OSA

ProSomnus (OSA)

ProSomnus Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OSA

1 2 Next >>

Date	Time	Source	Headline	Symbol	Company
27/03/2024	07:05	GlobeNewswire Inc.	ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results	NASDAQ:OSA	ProSomnus Inc
18/03/2024	22:12	IH Market News	Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks	NASDAQ:OSA	ProSomnus Inc
16/03/2024	11:01	GlobeNewswire Inc.	ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call	NASDAQ:OSA	ProSomnus Inc
23/02/2024	00:30	GlobeNewswire Inc.	ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
21/02/2024	08:05	GlobeNewswire Inc.	ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024	NASDAQ:OSA	ProSomnus Inc
31/01/2024	00:00	GlobeNewswire Inc.	ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA	NASDAQ:OSA	ProSomnus Inc
30/01/2024	00:00	GlobeNewswire Inc.	ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices	NASDAQ:OSA	ProSomnus Inc
09/01/2024	00:00	GlobeNewswire Inc.	ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
20/12/2023	00:00	GlobeNewswire Inc.	Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices	NASDAQ:OSA	ProSomnus Inc
10/11/2023	08:17	GlobeNewswire Inc.	ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results	NASDAQ:OSA	ProSomnus Inc
01/11/2023	07:05	GlobeNewswire Inc.	ProSomnus Announces Third Quarter 2023 Investor Call and Business Update	NASDAQ:OSA	ProSomnus Inc
04/10/2023	07:05	GlobeNewswire Inc.	ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference	NASDAQ:OSA	ProSomnus Inc
21/09/2023	22:30	GlobeNewswire Inc.	ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations	NASDAQ:OSA	ProSomnus Inc
14/09/2023	22:30	GlobeNewswire Inc.	ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences	NASDAQ:OSA	ProSomnus Inc
23/08/2023	22:00	GlobeNewswire Inc.	Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy with ProSomnus Devices is Non-Inferior to CPAP Therapy for the Treatment of Moderate to Severe Obstructive Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
03/08/2023	22:09	GlobeNewswire Inc.	ProSomnus Reports Record Second Quarter 2023 Top-Line Financial Results	NASDAQ:OSA	ProSomnus Inc
13/07/2023	22:00	GlobeNewswire Inc.	ProSomnus to Design Head-to-Head Clinical Trial vs. Hypoglossal Nerve Stimulation	NASDAQ:OSA	ProSomnus Inc
06/07/2023	22:29	GlobeNewswire Inc.	ProSomnus Announces Second Quarter 2023 Investor Call and Business Update	NASDAQ:OSA	ProSomnus Inc
28/06/2023	22:00	GlobeNewswire Inc.	71% of Self-identified Snorers Have Never Consulted a Healthcare Professional	NASDAQ:OSA	ProSomnus Inc
09/06/2023	06:08	GlobeNewswire Inc.	Data Presented at the 2023 SLEEP Annual Meeting Strengthens Evidence for ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
30/05/2023	22:00	GlobeNewswire Inc.	Data Presented at the 2023 American Academy of Dental Sleep Medicine and the American Thoracic Society Meetings Further Validate ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
10/05/2023	06:00	GlobeNewswire Inc.	ProSomnus Reports First Quarter 2023 Financial Results	NASDAQ:OSA	ProSomnus Inc
26/04/2023	23:00	GlobeNewswire Inc.	ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences	NASDAQ:OSA	ProSomnus Inc
25/04/2023	06:05	GlobeNewswire Inc.	Study to be Presented at European Respiratory Society and European Sleep Research Society’s Sleep and Breathing 2023 Conference Demonstrates Efficacy of ProSomnus Precision Oral Appliances	NASDAQ:OSA	ProSomnus Inc
18/04/2023	22:00	GlobeNewswire Inc.	ProSomnus® Announces Publication of Four Accepted Abstracts in the Journal of Dental Sleep Medicine in Advance of Annual Meeting	NASDAQ:OSA	ProSomnus Inc
05/04/2023	22:00	GlobeNewswire Inc.	ProSomnus® Receives Additional U.S. Utility Patent Covering Iterative Titration Technology for Company’s Novel Precision Sleep Apnea Medical Devices	NASDAQ:OSA	ProSomnus Inc
31/03/2023	07:05	GlobeNewswire Inc.	ProSomnus Reports Fourth Quarter and Fiscal Year 2022 Financial Results	NASDAQ:OSA	ProSomnus Inc
21/03/2023	23:00	GlobeNewswire Inc.	ProSomnus® Receives Patent Allowance Covering Automated Manufacturing Process for Company’s Novel Precision Sleep Apnea Medical Devices	NASDAQ:OSA	ProSomnus Inc
17/03/2023	07:05	GlobeNewswire Inc.	ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023	NASDAQ:OSA	ProSomnus Inc
11/03/2023	00:00	GlobeNewswire Inc.	ProSomnus® Announces Acceptance of Abstract at European Respiratory Society and European Sleep Research Society’s Sleep and Breathing 2023 Conference	NASDAQ:OSA	ProSomnus Inc